– Strategic clinical program for hepatitis B and D with potential for multiple value drivers in 2022 –
– Virtual R&D Day webcastscheduled for today, Wednesday, April 27, at 12:00 pm ET / 9:00 am PT–
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.